CDDRX
Price
$34.69
Change
-$0.08 (-0.23%)
Updated
Jun 5 closing price
Net Assets
42.09B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

CDDRX vs RMEBX

Header iconCDDRX vs RMEBX Comparison
Open Charts CDDRX vs RMEBXBanner chart's image
Columbia Dividend Income Inst2
Price$34.69
Change-$0.08 (-0.23%)
VolumeN/A
Net Assets42.09B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
CDDRX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CDDRX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDDRX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. CDDRX (42.1B). CDDRX pays higher dividends than RMEBX: CDDRX (1.72) vs RMEBX (1.16). CDDRX was incepted earlier than RMEBX: CDDRX (13 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than CDDRX (0.58). RMEBX is a more actively managed with annual turnover of: 31.00 vs. CDDRX (14.00). CDDRX has a lower initial minimum investment than RMEBX: CDDRX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. CDDRX (7.26). CDDRX return over 5 years is better than : 58.97 vs. RMEBX (49.85).
CDDRXRMEBXCDDRX / RMEBX
Total Expense Ratio0.581.0754%
Annual Report Gross Expense Ratio0.581.0754%
Fund Existence13 years11 years-
Gain YTD3.7485.34970%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets42.1B105B40%
Annual Yield % from dividends1.721.16148%
Returns for 1 year7.268.3087%
Returns for 3 years21.9917.96122%
Returns for 5 years58.9749.85118%
Returns for 10 years105.2068.21154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA